Literature DB >> 475889

Chromosomal breakage in Crohn's disease: anticlastogenic effect of D-penicillamine and L-cysteine.

I Emerit, J Emerit, A Levy, M Keck.   

Abstract

The incidence of chromosome breakage was found to be elevated in 42 patients with Crohn's disease. This phenomenon was much more striking in cultures set up with TCM 199 than in cultures set up with RPMI 1629 rich in L-cysteine. The drug D-penicillamine, a close analog of L-cysteine, gave an apparent therapeutic response in several patients and reduced the chromosome breakage frequency in the lymphocytes of these patients in vitro and in vivo.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 475889     DOI: 10.1007/bf00295589

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  12 in total

1.  [100 cases of common rheumatoid polyarthritis, treated with D-penicillamin].

Authors:  J P Camus; J Crouzet; P Guillien; C Benichou; J A Lievre
Journal:  Ann Med Interne (Paris)       Date:  1974-01

2.  Antimutagens. Data and problems.

Authors:  E Gebhart
Journal:  Humangenetik       Date:  1974

3.  Breakage factor in systemic sclerosis and protector effect of L-cysteine.

Authors:  I Emerit; A Levy; E Housset
Journal:  Humangenetik       Date:  1974

4.  Controlled trial of D(-)penicillamine in severe rheumatoid arthritis.

Authors: 
Journal:  Lancet       Date:  1973-02-10       Impact factor: 79.321

5.  Selective inhibition of poliovirus growth by d-Penicillamine in vitro.

Authors:  G L Gessa; B Loddo; G Brotzu; M L Schivo; A Tagliamonte; A Spanedda; G Bo; W Ferrari
Journal:  Virology       Date:  1966-12       Impact factor: 3.616

6.  Crohn's disease and cancer.

Authors:  D D Weedon; R G Shorter; D M Ilstrup; K A Huizenga; W F Taylor
Journal:  N Engl J Med       Date:  1973-11-22       Impact factor: 91.245

7.  Chromosome studies in 14 patients with disseminated sclerosis.

Authors:  I Emerit; R Marteau
Journal:  Humangenetik       Date:  1971

8.  Chromosomal aberrations in patients with ulcerohaemorrhagic colitis.

Authors:  B Konstantinova; N Nedkova-Bratanowa
Journal:  Digestion       Date:  1969       Impact factor: 3.216

9.  Superoxide dismutase activity of copper-penicillamine: possible involvement of Cu(I) stabilized sulphur radical.

Authors:  M Younes; U Weser
Journal:  Biochem Biophys Res Commun       Date:  1977-10-24       Impact factor: 3.575

Review 10.  Chromosomal breakage in systemic sclerosis and related disorders.

Authors:  I Emerit
Journal:  Dermatologica       Date:  1976
View more
  5 in total

1.  Functional deficiency of fibroblasts heterozygous for Bloom syndrome as specific manifestation of the primary defect.

Authors:  C R Bartram; H W Rüdiger; U Schmidt-Preuss; E Passarge
Journal:  Am J Hum Genet       Date:  1981-11       Impact factor: 11.025

2.  Cytopathic effects in cultures inoculated with material from Crohn's disease.

Authors:  C O Moráin; H Prestage; P Harrison; A J Levi; D A Tyrrell
Journal:  Gut       Date:  1981-10       Impact factor: 23.059

3.  Clastogenic factors as potential biomarkers of increased superoxide production.

Authors:  Ingrid Emerit
Journal:  Biomark Insights       Date:  2007-12-11

4.  [41-year old patient with obscure diarrhea].

Authors:  T Brünnler; F Bataille; F Hofstädter; G Birkenfeld; J Schölmerich
Journal:  Internist (Berl)       Date:  2009-09       Impact factor: 0.743

5.  Clastogenic activity from Bloom syndrome fibroblast cultures.

Authors:  I Emerit; P Cerutti
Journal:  Proc Natl Acad Sci U S A       Date:  1981-03       Impact factor: 11.205

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.